Bibliografía:

1. Spinedi E, Chiasari A, Gaillard RC. Neuroendocrine-immune interactions. Front. Horm. Res. 29: 91-107, 2002.
2. Scacchi P. Unidad hipotálamo-hipofisaria. Separata Montpellier 2005.
3. Spinedi E. Neurotransmisores. Separata Montpellier 2005.
4. Gaillard RC,  Daneva T, Hadid R, Muller K, Spinedi E. The hypothalamus.pituitary-adrenal axis of athymic Swiss nude mice: The implications of T lymphocytes in the ACTH release from immune cells. Proc. New York Acad. Sci. 80: 480-490, 1998. 
5. Gaillard RC,  Spinedi E, Chautard T, Pralong FP. Cytokines, leptin and the hypothalamus.pituitary-adrenal axis. Ann. New York Acad. Sci. 917: 647-657, 2000.
6. Moguilevsky JA. Fisiología endócrina y de la reproducción. 5ª ed. Buenos Aires, 2003.
7. Brann DW, Mahesh VB. Excitatory aminoacids: evidence for a role in the control of reproduction and anterior pituitary hormone secretion. Endocrine Reviews 18: 678, 1997.
8. Gaillard RC. Cytokines in the neuroendocrine system. Int. Rev. Immunol. 17: 181-216, 1998.
9. Farrar MA, Schreiber RD. The molecular cell biology of IF-gamma and its receptors. Ann. Rev. Immunol. 11: 571-611, 1993.
10. Trinchieri G. Interleukin 12, a pro-inflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptative immunity. Ann. Rev. Immunol. 13: 251-276, 1995.
11. Liew FY, McInnes IB. Role of interleukin 15 and interleukin 18 in inflammatory responses. Ann. Rheum. Dis. 61: II 100-II 102, 2002.
12. Conti P, Kempuraj D, Kandere K, DiGioacchino M. Interleukin 16 network in inflammatory and allergy. Allergy Asthma Proc. 23: 103-108, 2002.
13. Aggarwall S, Gurney AL: IL 17: Prototype member of an emerging cytokine family. J Leukoc Biol. 71: 1-8, 2002.
14. Biet F, Locht C, Kremer L: Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J. Mol. Med. 80: 147-162, 2002
15. Vasalli P. The pathophysiology of tumor necrosis factor. Ann. Rev. Immnol. 10: 411-452, 1992.
16. de Kloet ER. Stress in the brain. Eur. J. Pharmacol. 405: 187-198, 2000.
17. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci 94: 557-572, 1998.
18. Herrmann M, Schölmerich J, Straub RH. Estrés y enfermedades reumáticas. Rheum. Dis. Clin. N. Amer (Edición española) 2: 767-794, 2000.
19. Greca A: Psiquis e hipertensión. Boletín de la Sociedad Argentina de Hipertensión Arterial 3: 3-7, 2000.
20. Coelho R, Ramos E, Prata J, Maciel MJ, Barros H: Acute myocardial infarction: psychosocial and cardiovascular risk factors in men. J. Cardiovasc. Risk 6(3): 157-162, 1999.
21. Ross R. Atherosclerosis – An inflammatory disease. N. Engl. J. Med. 340: 115-126, 1999.
22. Rajavashisth TB, Andalibi A, Territo MC, et al. Induction of endothelial cell expresion of granulocyte and macrophage colony-stimulating factors by modified low density lipoproteins. Nature 344: 254-257, 1990.
23. Hajjar DP, Haberland ME. Lipoprotein trafficking in vascular cells: Molecular Trojan horses and cellular saboteurs. J. Biol. Chem. 272: 22975-22978, 1997.
24. Greca A. Síndrome antifosfolipídico y aterosclerosis. En: Battagliotti CA, Bertolaccini ML, Pons-Estel BA, Carreras LO. Síndrome antifosfolipídico. Actualización clínica y terapéutica. Editor: Carlos A. Battagliotti. Rosario, 2002.